AlphaMaven AlphaMaven

Benchmark reiterates Buy on Strive stock, cites risk management edge By Investing.com

Reported by Investing ·Cavesting ·Ukvesting +1 more
Aug 20, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Benchmark reiterated a Buy rating on Strive Enterprises Inc. (NASDAQ: ASST) with a $32.00 price target as the company prepares to launch a daily dividend structure.
  • • Five analysts recommend buying Strive stock, with zero sell recommendations, resulting in a "Strong Buy" overall rating and +80.58% upside potential based on current valuations.
  • • Benchmark's reiteration emphasizes risk management as a key differentiator for Strive, citing this as a focal point ahead of the daily dividend rollout.
  • • HC Wainwright also maintains a Buy rating on Strive while trimming its price target to $36, indicating continued analyst confidence despite broader market volatility and the stock's 86% decline over the past year.
Summary
Benchmark has reiterated its Buy rating on Strive Enterprises Inc., maintaining a $32.00 price target as the company advances toward launching its daily dividend structure. The analyst firm highlights Strive's risk management capabilities as a critical competitive edge, positioning this as a significant catalyst for the stock ahead of the dividend initiative.

The analyst consensus surrounding Strive remains decidedly bullish. According to current market data, five analysts recommend buying the stock with zero sell recommendations, yielding a "Strong Buy" consensus rating. The stock exhibits +80.58% upside potential based on consensus price targets, indicating substantial valuation gap between current trading levels and analyst expectations.

HC Wainwright independently maintains its own Buy rating on Strive while moderating its price target to $36, demonstrating sustained conviction despite recent equity volatility. The broader market backdrop has challenged Strive's stock performance, with shares down 86% over the past year—a significant headwind that underscores the importance of the upcoming daily dividend launch and risk management positioning to re-establish investor confidence.

The daily dividend structure represents a strategic inflection point for Strive. Benchmark's emphasis on risk management in the context of this new capital distribution mechanism suggests the firm views Strive's operational framework as defensible relative to peers, even amid challenging market conditions. This positioning is particularly relevant for institutional investors evaluating income-generating equity strategies within volatile market environments.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

4 outlets

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Investing Benchmark reiterates Buy on Strive stock, cites risk management edge By Investing.com Cavesting Benchmark reiterates Hold on VolitionRX stock amid cost cuts By Investing.com - Investing.com Canada Ukvesting Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com Auvesting Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com Australia